Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Lien

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trialA Guerrieri-Gonzaga, L Baglietto, H Johansson, et al.
Clinical Endocrinology|January 1, 1995
Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patientsP E Lønning, S I Helle, D C Johannessen, et al.
Journal of Internal Medicine|July 5, 2012
Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidismM H E Christensen, E K R Pedersen, Y Nordbø, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2006
Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled studyJ Geisler, P E Lønning, L E Krag, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trialA Guerrieri-Gonzaga, L Baglietto, H Johansson, et al.
Clinical Endocrinology|January 1, 1995
Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patientsP E Lønning, S I Helle, D C Johannessen, et al.
Journal of Internal Medicine|July 5, 2012
Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidismM H E Christensen, E K R Pedersen, Y Nordbø, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2006
Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled studyJ Geisler, P E Lønning, L E Krag, et al.
Pageof 5